FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011751936> ?p ?o ?g. }

• W2011751936 endingPage "e83646" @default.
• W2011751936 startingPage "e83646" @default.
• W2011751936 abstract "Although the prognosis of patients with small (≤1cm) tumors is generally favorable, emerging data suggests that biological behavior varies between intrinsic subtypes in such patients. Furthermore, it still remains unclear whether HER2-positive pT1a-bN0M0 patients could benefit from adjuvant trastuzumab. For further evaluation, we sought to conduct a meta-analysis so as to get a better understanding of the prognosis for HER2-positive pT1a-bN0M0 patients and their survival benefit from adjuvant trastuzumab, accordingly, offering the implications for current practice.The PubMed database, the online proceedings of the American Society of Clinical Oncology (ASCO) Annual Meetings, the online proceedings of the San Antonio Breast Cancer Symposium, and the CD proceedings of the International St. Gallen Breast Cancer Conference were searched for all relevant studies published before September 2012. Relative risks (RRs) were used to compare the prognosis of different intrinsic subtypes for pT1a-bN0M0 breast cancer. Analyses were also performed to estimate the association between adjuvant trastuzumab and various survival outcomes.With eight eligible studies identified, this meta-analysis demonstrated a deleterious effect of HER2+ phenotype on disease-free survival (DFS; RR = 3.677, 95% CI 2.606-5.189, p <0.001) and distant disease-free survival (DDFS; RR = 3.824, 95% CI 2.249-6.501, p<0.001) as compared to HR+/HER2- subgroup. However, significant difference failed to be achieved in terms of any endpoint between HER2+ and triple negative breast cancer (TNBC). Besides, a marked improvement in DFS was observed with the addition of trastuzumab for HER2-positive pT1a-bN0M0 patients (RR = 0.323, 95% CI 0.191-0.547, p<0.001).This meta-analysis clarifies that intrinsic subtypes might be a reliable marker to predict the prognosis in pT1a-bN0M0 breast cancer. Besides, even for such early stage HER2-positive patients, adjuvant trastuzumab might bring significant survival benefit." @default.
• W2011751936 created "2016-06-24" @default.
• W2011751936 creator A5006099817 @default.
• W2011751936 creator A5057497297 @default.
• W2011751936 creator A5074669391 @default.
• W2011751936 creator A5076533749 @default.
• W2011751936 date "2014-01-02" @default.
• W2011751936 modified "2023-10-17" @default.
• W2011751936 title "For or against Adjuvant Trastuzumab for pT1a-bN0M0 Breast Cancer Patients with HER2-Positive Tumors: A Meta-Analysis of Published Literatures" @default.
• W2011751936 cites W1573898394 @default.
• W2011751936 cites W1966173991 @default.
• W2011751936 cites W1968442275 @default.
• W2011751936 cites W1988622440 @default.
• W2011751936 cites W1990536342 @default.
• W2011751936 cites W1991697331 @default.
• W2011751936 cites W2060942118 @default.
• W2011751936 cites W2081105116 @default.
• W2011751936 cites W2083892787 @default.
• W2011751936 cites W2086965131 @default.
• W2011751936 cites W2096818458 @default.
• W2011751936 cites W2097541112 @default.
• W2011751936 cites W2098460073 @default.
• W2011751936 cites W2098775844 @default.
• W2011751936 cites W2101979288 @default.
• W2011751936 cites W2113450161 @default.
• W2011751936 cites W2116362697 @default.
• W2011751936 cites W2117775530 @default.
• W2011751936 cites W2125435699 @default.
• W2011751936 cites W2125620887 @default.
• W2011751936 cites W2140354367 @default.
• W2011751936 cites W2146384083 @default.
• W2011751936 cites W2150408445 @default.
• W2011751936 cites W2150815608 @default.
• W2011751936 cites W2158818777 @default.
• W2011751936 cites W2161151800 @default.
• W2011751936 cites W2161426850 @default.
• W2011751936 cites W4243674373 @default.
• W2011751936 doi "https://doi.org/10.1371/journal.pone.0083646" @default.
• W2011751936 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3879252" @default.
• W2011751936 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24392090" @default.
• W2011751936 hasPublicationYear "2014" @default.
• W2011751936 type Work @default.
• W2011751936 sameAs 2011751936 @default.
• W2011751936 citedByCount "25" @default.
• W2011751936 countsByYear W20117519362014 @default.
• W2011751936 countsByYear W20117519362015 @default.
• W2011751936 countsByYear W20117519362016 @default.
• W2011751936 countsByYear W20117519362017 @default.
• W2011751936 countsByYear W20117519362018 @default.
• W2011751936 countsByYear W20117519362019 @default.
• W2011751936 countsByYear W20117519362020 @default.
• W2011751936 countsByYear W20117519362021 @default.
• W2011751936 countsByYear W20117519362022 @default.
• W2011751936 crossrefType "journal-article" @default.
• W2011751936 hasAuthorship W2011751936A5006099817 @default.
• W2011751936 hasAuthorship W2011751936A5057497297 @default.
• W2011751936 hasAuthorship W2011751936A5074669391 @default.
• W2011751936 hasAuthorship W2011751936A5076533749 @default.
• W2011751936 hasBestOaLocation W20117519361 @default.
• W2011751936 hasConcept C121608353 @default.
• W2011751936 hasConcept C126322002 @default.
• W2011751936 hasConcept C143998085 @default.
• W2011751936 hasConcept C187960798 @default.
• W2011751936 hasConcept C2777863537 @default.
• W2011751936 hasConcept C2777982462 @default.
• W2011751936 hasConcept C2779786085 @default.
• W2011751936 hasConcept C29456083 @default.
• W2011751936 hasConcept C530470458 @default.
• W2011751936 hasConcept C71924100 @default.
• W2011751936 hasConcept C95190672 @default.
• W2011751936 hasConceptScore W2011751936C121608353 @default.
• W2011751936 hasConceptScore W2011751936C126322002 @default.
• W2011751936 hasConceptScore W2011751936C143998085 @default.
• W2011751936 hasConceptScore W2011751936C187960798 @default.
• W2011751936 hasConceptScore W2011751936C2777863537 @default.
• W2011751936 hasConceptScore W2011751936C2777982462 @default.
• W2011751936 hasConceptScore W2011751936C2779786085 @default.
• W2011751936 hasConceptScore W2011751936C29456083 @default.
• W2011751936 hasConceptScore W2011751936C530470458 @default.
• W2011751936 hasConceptScore W2011751936C71924100 @default.
• W2011751936 hasConceptScore W2011751936C95190672 @default.
• W2011751936 hasIssue "1" @default.
• W2011751936 hasLocation W20117519361 @default.
• W2011751936 hasLocation W20117519362 @default.
• W2011751936 hasLocation W20117519363 @default.
• W2011751936 hasLocation W20117519364 @default.
• W2011751936 hasOpenAccess W2011751936 @default.
• W2011751936 hasPrimaryLocation W20117519361 @default.
• W2011751936 hasRelatedWork W1875770431 @default.
• W2011751936 hasRelatedWork W1990208537 @default.
• W2011751936 hasRelatedWork W1992437467 @default.
• W2011751936 hasRelatedWork W2029735288 @default.
• W2011751936 hasRelatedWork W2082392604 @default.
• W2011751936 hasRelatedWork W2398147395 @default.
• W2011751936 hasRelatedWork W2464650279 @default.
• W2011751936 hasRelatedWork W2554003122 @default.
• W2011751936 hasRelatedWork W2935266072 @default.
• W2011751936 hasRelatedWork W3200968610 @default.

• next